Foreword to ‘The current status and future perspectives on the management of stage III NSCLC: a focus on unresectable cancer treatment paradigms’

por Paz-Ares, Luis
Publicado 2020

Summary of ‘The current status and future perspectives on the management of stage III NSCLC: a focus on unresectable cancer treatment paradigms’

por Paz-Ares, Luis
Publicado 2020

Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re-Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-...

por Paz-Ares, Luis, Moecks, Joachim, Klughammer, Barbara
Publicado 2011

Impact of the COVID-19 outbreak on cancer patient flow and management: experience from a large university hospital in Spain

por Manso, Luis, De Velasco, Guillermo, Paz-Ares, Luis
Publicado 2020

Addressing CPI resistance in NSCLC: targeting TAM receptors to modulate the tumor microenvironment and future prospects

por Peters, Solange, Paz-Ares, Luis, Herbst, Roy S, Reck, Martin
Publicado 2022

KRAS oncogene in lung cancer: focus on molecularly driven clinical trials

por Kempf, Emmanuelle, Rousseau, Benoît, Besse, Benjamin, Paz-Ares, Luis
Publicado 2016

Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications

por Quintanal-Villalonga, A., Paz-Ares, Luis, Ferrer, Irene, Molina-Pinelo, S.
Publicado 2016

Corrigendum to “Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications”

por Quintanal-Villalonga, A., Paz-Ares, Luis, Ferrer, Irene, Molina-Pinelo, S.
Publicado 2018

Durvalumab in NSCLC: latest evidence and clinical potential

por Muñoz-Unceta, Nerea, Burgueño, Isabel, Jiménez, Elizabeth, Paz-Ares, Luis
Publicado 2018

Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer

por Marrugal, Ángela, Ojeda, Laura, Paz-Ares, Luis, Molina-Pinelo, Sonia, Ferrer, Irene
Publicado 2016

Corrigendum to “Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer”

por Marrugal, Ángela, Ojeda, Laura, Paz-Ares, Luis, Molina-Pinelo, Sonia, Ferrer, Irene
Publicado 2018

Pooled analysis of clinical outcome for EGFR TKI-treated patients with EGFR mutation-positive NSCLC

por Paz-Ares, Luis, Soulières, Denis, Moecks, Joachim, Bara, Ilze, Mok, Tony, Klughammer, Barbara
Publicado 2014

Treatment rationale and study design for a phase III, double-blind, placebo-controlled study of maintenance pemetrexed plus best supportive care versus best supportive care immedia...

por Paz-Ares, Luis G, Altug, Sedat, Vaury, Alexandra Thareau, Jaime, Jesús Corral, Russo, Francesca, Visseren-Grul, Carla
Publicado 2010

Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis

por Paz-Ares, Luis, Soulières, Denis, Melezínek, Ivan, Moecks, Joachim, Keil, Lorenz, Mok, Tony, Rosell, Rafael, Klughammer, Barbara
Publicado 2010

Second-line Treatment of Non-Small Cell Lung Cancer: Focus on the Clinical Development of Dacomitinib

por Zugazagoitia, Jon, Díaz, Asunción, Jimenez, Elisabeth, Nuñez, Juan Antonio, Iglesias, Lara, Ponce-Aix, Santiago, Paz-Ares, Luis
Publicado 2017

Efficacy of T-Cell Receptor-Based Adoptive Cell Therapy in Cutaneous Melanoma: A Meta-Analysis

por Yarza, Ramon, Bover, Mateo, Herrera-Juarez, Mercedes, Rey-Cardenas, Macarena, Paz-Ares, Luis, Lopez-Martin, Jose A, Haanen, John
Publicado 2023

Treating KRAS-mutant NSCLC: latest evidence and clinical consequences

por Garrido, Pilar, Olmedo, María Eugenia, Gómez, Ana, Paz Ares, Luis, López-Ríos, Fernando, Rosa-Rosa, Juan Manuel, Palacios, José
Publicado 2017

A narrative review of methods for the identification of ALK fusions in patients with non-small cell lung carcinoma

por Hernandez, Susana, Conde, Esther, Alonso, Marta, Illarramendi, Adrian, Bote de Cabo, Helena, Zugazagoitia, Jon, Paz-Ares, Luis, Lopez-Rios, Fernando
Publicado 2023

An open label randomized Phase III trial of nivolumab or nivolumab plus ipilimumab vs platinum doublet chemotherapy (PT-DC) in patients with chemotherapy-naïve stage IV or recurren...

por Hellmann, Matthew, Ramalingam, Suresh, Reck, Martin, O'Byrne, Ken, Paz-Ares, Luis, Harbison, Christopher T, Bhagavatheeswaran, Prabhu, Nathan, Faith, Brahmer, Julie
Publicado 2015

Impact of Heat Shock Protein 90 Inhibition on the Proteomic Profile of Lung Adenocarcinoma as Measured by Two-Dimensional Electrophoresis Coupled with Mass Spectrometry

por Marrugal, Ángela, Ferrer, Irene, Pastor, Maria Dolores, Ojeda, Laura, Quintanal-Villalonga, Álvaro, Carnero, Amancio, Molina-Pinelo, Sonia, Paz-Ares, Luis
Publicado 2019